Future prospects in the treatment of erectile dysfunction: focus on avanafil
Amjad Alwaal, Raed Al-Mannie, Serge Carrier Division of Urology, McGill University Health Centre, Montreal, Quebec, Canada Abstract: The treatment of erectile dysfunction (ED) has been revolutionized in the last 15 years with the introduction of type 5 phosphodiesterase (PDE5) inhibitors. Their effi...
Main Authors: | Alwaal A, Al-Mannie R, Carrier S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-10-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/future-prospects-in-the-treatment-of-erectile-dysfunction-focus-on-ava-a8491 |
Similar Items
-
Avanafil for treatment of erectile dysfunction: review of its potential
by: Burke RM, et al.
Published: (2012-08-01) -
Avanafil for the treatment of erectile dysfunction: initial data and clinical key properties
by: George T. Kedia, et al.
Published: (2013-02-01) -
A comparison of the available phosphodie­sterase-5 inhibitors in the treatment of erectile dysfunction: a focus on avanafil
by: Evans JD, et al.
Published: (2015-08-01) -
Avanafil for male erectile dysfunction: a systematic review and meta-analysis
by: Yuan-Shan Cui, et al.
Published: (2014-06-01) -
Avanafil for erectile dysfunction in elderly and younger adults: differential pharmacology and clinical utility
by: Katz EG, et al.
Published: (2014-08-01)